Lower than normal expression of brain nitric oxide synthase gene in the hypothalamus of deoxycorticosterone acetate-salt hypertensive rats

Journal of Hypertension

Volumn 16, Issue 4, 1998, Pages 495-502

  Nanbu, Akira ^a   Nishimura, Masato ^a   Takahashi, Hakuo ^b   Ohtsuka, Ken ^a   Sakamoto, Masatoshi ^a   Yoshimura, Manabu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain; Constitutive nitric oxide synthase; Deoxycorticosterone acetate salt; Hypertension; Hypothalamus; Nitric oxide; Sodium

Indexed keywords

DEOXYCORTICOSTERONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN STEM; CONTROLLED STUDY; GENE EXPRESSION; HYPERTENSION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALT INTAKE;

EID: 0031977842     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816040-00011     Document Type: Article

References (32)

1. Plamer RMJ, Ashton DS, Moncada S, Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-666.
2. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336:385-388.
3. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347:768-770.
4. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992; 46:755-784.
5. Arvalo R, Sanchez F, Alonso JR, Carretero J, Vazquez R, Aijn J. NADPH-diaphorase activity in the hypothalamus magnocellular neurosecretory nuclei of the rat. Brain Res Bull 1992; 28:599-603.
6. Miyagawa A, Okamura H, Ibata Y. Coexistence of oxytocin and NADPH-diaphorase in magnocellular neurons of the paraventricular and the supraoptic nuclei of the rat hypothalamus. Neurosci Lett 1994; 171:13-16.
7. Sanchez F, Alonso JR, Arvalo R, Blanco E, Aijn J, Vazquez R. Coexistence of NADPH-diaphorase with vasopressin and oxytocin in the hypothalamic neurosecretory nuclei of the rat. Cell Tissue Res 1994; 276:31-34.
8. Dun NJ, Dun SL. Forstermann U. Nitric oxide synthase immuoreactivity in rat pontine medullary neurons. Neuroscience 1994; 59:429-445.
9. Ohta A, Takagi H, Matsui T, Hamai T, Iida S, Esumi H, Localization of nitric oxide synthase-immunoreactive neurons in the solitary nucleus and ventrolateral medulla oblongata of the rat: their relation to catecholaminergic neurons. Neurosci Lett 1993; 158:33-35.
10. Lewis SJ, Ohta H, Machado B, Bates JN, Talman WT. Microinjection of S-nitrosocysteine into the nucleus tractus solitarii decreases arterial pressure and heart rate via activation of soluble guanylate cyclase. Eur J Pharmacol 1991; 202:135-136.
11. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res 1992; 70:607-611.
12. Togashi H, Sakuma I, Yoshika M, Kobayashi T, Yasuda H, Kitabatake A, et al. A central nervous system action of nitric oxide in blood pressure regulation J Pharmacol Exp Ther 1992; 262:343-347.
13. Huang Z. Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA, Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265:1883-1885.
14. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239-242.
15. Takahashi H, Iyoda I, Yamasaki H, Takeda K, Okaima H, Yoshimura M, et al. Retardation of development of hypertension in DOCA-salt rats by renal denervation. Jap Circ J 1984; 48:567-574.
16. Nishimura M, Takahashi H, Matsusawa M, Ikegaki I, Sakamoto M, Yoshimura M, et al. Chronic intracerebroventricular infusions of endothelin elevate arterial pressure in rats. J Hypertens 1991; 9:71-76.
17. Nishimura M, Milsted A, Block CH, Brosnihan KB, Ferrario CM. Tissue renin-angiotensin systems in renal hypertension. Hypertension 1992; 20:158-167.
18. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed R, Snyder SH. Cloned expressed nitric oxide synthase structurally resembles cytochrome p-450 reductase. Nature 1991; 351:714-718.
19. Fort P, Marty L, Pichaczk M, Sabrouty SE, Dani C, Janteur P, et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigene family. Nucl Acids Res 1985; 13:1431-1442.
20. Yoshimura M, Yamazaki H, Takashina R, Kambara S, Iyoda I, Takahashi H, et al. The significance of duration of salt loading on cardiovascular response and urinary excretion of catecholamine in rats. Endocrinol Japan 1986; 33:169-175.
21. Brownie AC. The adrenal cortex in hypertension. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis and management. New York: Raven Press; 1990. pp. 63-77.
22. Krukoff TL, Gehlen F, Ganten D, Wanger J, Gene expression of brain nitric oxide synthase and soluble guanylate cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats. Hypertension 1995; 26:171-176.
23. Scoggins BA, Coghlan JP, Denton DA, Mason RT, Whitworth JA. A review of mechanisms involved in the production of steroid induced hypertension with particular reference to ACTH dependent hypertension. In: Mangero F, Biglieri EG, Edwards CRW (editors): Endocrinology of hypertension. New York: Academic Press; 1982. pp. 41-67.
24. Kadowaki K, Kishimoto J, Leng G, Emson PC, Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamus-hypophysila system after chronic salt loading: evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology 1994; 134:1011-1017.
25. Nanbu A, Takahashi H, Nishimura M, Sakamoto M, Nakanishi T, Yoshimura M, et al. Roles of endogenous nitric oxide production in the development of DOCA-salt hypertension in rats. J Clin Exp Med 1994; 169:829-830.
26. Takahashi H, Hara K, Komiyama Y, Masuda M, Murakami T, Nishimura M, et al. Mechanism of hypertension induced by chronic inhibition of nitric oxide in rats, Hypertens Res 1995; 18:319-324.
27. Takeda K, Bunag RD. Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats. Hypertension 1980; 2:97-101.
28. Ferrario CM, Mohara O, Ueno Y, Brosnihan KB. Hemodynamic and neurohormonal changes in the development of DOC hypertension in the dog. Am J Med Sci 1988; 295:352-359.
29. Bravo EL, Tarazi RC, Dustan HP, Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs. Circ Res 1977; 40 (suppl 1):1140-1145.
30. Philipp T, Luth B, Wucherer G, Distler A. Mechanism of mineralocorticoid-induced hypertension in man. In: Kaujman W, Wambach HA, Meurer KA (editors): Mineralocorticoid hypertension. New York: Springer-Verlag 1982. p. 129-139.
31. Tagawa T, Imaizumi T, Harada S, Endo T, Shiramoto M, Hirooka Y, et al. Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices. Circ Res 1994; 75:70-76.
32. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 1991; 132:47-50.